Total Number of Communication Reports: 23
Monthly communication reports in the last 6 months: 0
Biotechnology, data, life sciences, drug development ecosystem, drug target discovery and systems biology research
Christopher Gardner, CEO
End date of the last completed financial year: 2021-12-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Atlantic Canada Opportunities Agency (ACOA) | $266,291.25 | Yes |
National Research Council (NRC) | $193,422.56 | Yes |
Address:
53 Bond Street, Suite 100
St. John's, NL A1C 1S9
Canada
Telephone number:
800-296-3481
Sequence Bio is not a subsidiary of any other parent companies.
Sequence Bio does not have any subsidiaries that could have a direct interest in the outcome of the undertaking